No Detail Found!

Significance of Staphylococcus Haemolyticus in Hospital Acquired Infections

Author(s)
Betty Daniel Postgraduate Department of Botany, St. Josephs College ,PG & Research Centre Bangalore,Bangalore,India
Mehvish Saleem Postgraduate Department of Botany, St. Josephs College ,PG & Research Centre Bangalore,Bangalore,India
Gousia Naseer Division of Clinical Microbiology, Trans world Muslim University Diagnostic Center,Jammu &Kashmir,India
Alsaba Fida Department of Microbiology, Government Medical College Srinagar, Jammu &Kashmir,,India
Abstract
Staphylococcus haemolyticus is a commensal on skin in human beings and a member of coagulase negative staphylococci (CoNS). It is abundantly found in inguinal areas, perineum and axillae. S. haemolyticus is a well-known opportunistic pathogen and the most recurrently isolated among CoNS after S. epidermidis. It is the second most frequent cause of nosocomial infections associated with the insertion of medical devices. Staphylococcus haemolyticus also represents a multi-drug resistant phenotype recognized among CoNS. Its ability and pattern of forming biofilms that are different from other staphylococcus species makes it a complicated pathogen to treat. A multidisciplinary approach towards the awareness and control of infections due to CoNS will reduce the disease burden. This review describes the characteristics of S. haemolyticus along with mechanism of antimicrobial resistance, pathogenecity and clinical importance.
Publication Details
Page(s) 119-125
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 4, Issue: 3, Year: 2014

Request the full text from PASTIC

Keywords
Staphylococcus Aureus, Bio-films, Coagulase Negative Staphylococci, Glycopeptide resistance, Bloodstream Infections (BSI)
References
Barros EM,Ceotto H,Bastos MC,Dos Santos KR,Giambiagi-Demarval M .2012 .Staphylococcus haemolyticus as an important hospital pathogen and carrier of methicillin resistance genes. J Clin Microbiol, 50(1) : 166-168.
. .. , : .
Krieg ,Rainey ,Karl-Heinz Schleifer . .Bergey's Manual of Systematic Bacteriology. 3 The Firmicutes. , : .
Biavasco F,Giovanetti E,Montanari MP,Lupidi R,Varaldo PE .1991 .Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species. J Antimicrob Chemother, 27(1) : 71-79.
Biavasco F,Vignaroli C,Varaldo PE .2000 .Glycopeptide resistance in coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis, 19(6) : 403-417.
Billot-Klein D,Gutmann L,Bryant D,Bell D,Van Heijenoort J,Grewal J .1996 .Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics. J Bacteriol, 178(15) : 4696-4703.
.2013 .Centers for Disease Control and Prevention, "Antibiotic Resistance Questions & Answers". Get Smart: Know When Antibiotics Work 30 June 2009. Retrieved 20 March, : .
Robicsek .,Jacoby A,Hooper GA,DC GA . .The worldwide emergence of plasmid-mediated quinolone resistance. cite_notepmid2115217-2 8, : .
Infect Dis Lancet .2006 .. , 6(10) : 629-40.
Bozdogan B1,Esel D,Whitener C,Browne FA,Appelbaum PC,Chemother J Antimicrob .2003 .Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the HersheyMedical Center. , 52(5) : 864-868.
Froggatt JW,Johnston JL,Galetto DW,Archer GL . .. , : .
.1989 .Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus. Antimicrob Agents Chemother, 33(4) : 460-466.
Raponi G,Ghezzi MC,Gherardi G,Dicuonzo G,Caputo D,Venditti M . .. , : .
.2005 .Antimicrobial susceptibility, biochemical and genetic pr ofiles of Staphylococcushaemolyticus strains isolated fromthe bloodstream of patients hospitalized in critical care units. J Chemother, 17(3) : 264-269.
Berglund C,Söderquist B. .2008 .The origin of a methicillinresistant Staphylococcus aureus isolate at a neonatal ward in Sweden-possible horizontal transfer of a staphylococcal cassette chromosome mec between methicillin-resistant Staphylococcus haemolyticus and Staphylococcus aureus. Clin Microbiol Infect, 14(11) : 1048-1056.
Takeuchi F,Watanabe S,Baba T,Yuzawa H,Ito T,Morimoto Y .2005 .Whole-genome sequencing of staphylococcus haemolyticus uncovers the extreme plasticity of its genome and the evolution of humancolonizing staphylococcal species. J Bacteriol, 187(21) : 7292-7308.
Working International .2009 .Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWGSCC). Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCC mec elements. Antimicrob. Agents Chemother, 53(12) : 4961-4967.
Vignaroli C,Biavasco F,Varaldo PE .2006 .Interactions between Glycopeptides and β-Lactams against Isogenic Pairs of Teicoplanin Susceptible and Resistant Strains of Staphylococcus haemolyticus. Antimicrobial Agents and Chemotherapy, 50(7) : 2577-2582.
Domaracki BE,Evans A,Preston KE,Fraimow H,Venezia RA .1998 .Increased oxacillin activity associated with glycopeptides in coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis, 17(3) : 143-150.
HF Chambers .1997 .Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev, 10(4) : 781-791.
Caierao J,Musskopf M,Superti S,Roesch E,Dias CG,d'Azevedo PA CG .2004 .Evaluation of phenotypic methods for methicillin resistance characterization in coagulasenegative staphylococci (CNS). J Med Microbiol, 53(12) : 1195-1199.
Chiew YF,Charles M,Johnstone MC,Thompson KM,Parnell KD,Penno EC .2007 .Detection of vancomycin heteroresistant Staphylococcus haemolyticus and vancomycin intermediate resistant Staphylococcus epidermidis by means of vancomycin screening agar. Pathology, 39(3) : 39375-39377.
Blans M,Troelstra A .2001 .Glycopeptide resistance in Staphylococcus haemolyticus during treatment with teicoplanin. Infect Control Hosp Epidemiol, 22(5) : 263-264.
Bertin M,Muller A,Bertrand X,Cornette C,Thouverez M,Talon D .2004 .Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis, 23(5) : 375-379.
Biavasco F,Pugnaloni A,Lupidi R,Biagini G,Varaldo PE .1996 .An electron microscopic study of clinical and laboratory-derived strains of teicoplaninresistant Staphylococcus haemolyticus. Microb Drug Resist, 2(2) : 239-243.
Viale P,Stefani S. .2006 .Vascular catheter-associated infections: a microbiological and therapeutic update. J Chemother, 18(3) : 235-249.
Fredheim EG,Klingenberg C,Rohde H,Frankenberger S,Gaustad P,Flaegstad T,Sollid JE .2009 .Biofilm formation by Staphylococcus haemolyticus. J Clin Microbiol, 47(4) : 1172-1180.
Heilmann C,Hussain M,Peters G,Gotz F .1997 .Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol, 24(5) : 1013-1024.
Davis SL1,Gurusiddappa S,McCrea KW,Perkins S,Mack D,Fischer W,Krokotsch A,Leopold K,Hartmann R,Egge H .2001 .The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Biol Chem, 276(30) : 27799.
Bacteriol J .1996 .. , 178(1) : 175-183.
Toledo-Arana A,Merino N,Vergara-Irigaray M,Débarbouillé M,Penadés JR,Lasa I. .2005 .Staphylococcus aureus develops an alternative, ica-independent biofilm in the absence of the arlRS two-component system. J Bacteriol, 187(15) : 5318-5329.
Frank KL,Patel R .2007 .Poly-N-acetylglucosamine is not a major component of the extracellular matrix in biofilms formed by icaADBC-positive Staphylococcus lugdunensis isolates. Infect Immun, 75(10) : 4728-4742.
.2007 .Persistent strains of coagulase-negative staphylococci in a neonatal intensive care unit: virulence factors and invasiveness. Clin Microbiol Infect, 13(11) : 1100-1111.
Microbiol Mol .1997 .. , 24(5) : 1013-1024.
Cucarella C,Solano C,Valle J,Amorena B,Lasa I,Penadés JR .2001 .Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol, 183(9) : 2888-2896.
Hussain M,Herrmann M,von Eiff C,Peters F,G. F .1997 .A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect Immun, 65(2) : 519-524.
Flahaut S,Vinogradov E,Kelley KA,Brennan S,Hiramatsu K,Lee JC,Valle J,Gomez-Lucia E,Piriz S,Goyache J,Orden JA,Vadillo S. .1990 .Enterotoxin production by staphylococci isolated from healthy goats. Appl Environ Microbiol, 56(5) : 1323-6.
Vasconcelos NG1,Pereira VC,Araújo Júnior JP,Costerton JW,Stewart PS,Greenberg EP .2011 .Bacterial biofilms: a common cause of persistent infections. J Appl Microbiol, 111(3) : 749.
Science .1999 .. , 284(5418) : 1318-1322.
.2000 .Gram-positive pathogens. , : 450-462.
Rosenthal VD,Maki DG,Salomao R,Moreno CA,Mehta Y,Higuera F .2006 .Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med, 145(8) : 582-591.
Klingenberg C1,Rønnestad A,Anderson AS,Abrahamsen TG,Zorman J,Villaruz A . .. , : .
.2007 .Persistent strains of coagulase-negative staphylococci in a neonatal intensive care unit: virulence factors and invasiveness. Clin Microbiol Infect, 13(11) : 1100-1111.
.2006 .Antimicrobial resistance and production of biofilms in clinical isolates of coagulase-negative Staphylococcus strains. Biol Pharm Bull, 29(8) : 1592-1596.
Climo MW,Patron RL,Archer GL .1999 .Combinations of vancomycin and β-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin. Antimicrob Agents Chemother, 43(7) : 1747-1753.
Immunity .2007 .. , 26(2) : 149-161.
Joseph F John and Alexander M Harvin ,Hill ML,Baldwin L,Slaughter JC,Walsh WF,Weitkamp JH,Timsit JF,Schwebel C,Bouadma L,Geffroy A,Garrouste-Orgeas M,Pease S,Herault MC .2010 .the elimination of catheter related bloodstream infections 2009. www. J Perinatol, 30(7) : 469-473.
.2009 .Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA, 301(12) : 1231-1241.
0

Citations

0

Downloads

12

Views